Focus on Depression: Major depressive disorder target of $3.13 million Tulane study

zhao

Dr. Jinying Zhao is studying the causes of major depressive disorder. Photo: Paula Burch-Celentano

Tulane University has received a five-year $3.13 million grant from the National Institute of Mental Health to study the causes of major depressive disorder (MDD).

“Major depressive disorder is a devastating psychiatric disorder that affects millions of Americans,” says Dr. Jinying Zhao, associate professor of epidemiology at the Tulane School of Public Health and Tropical Medicine and principal investigator.

The research team wants to identify alterations of genetic makeup (“epigenetic” changes) that may cause the disorder. “Epigenetic changes are related to many psychosocial, behavioral and/or environmental factors,” says Zhao. “For MDD, stressful early life events are believed to play an important role in causing the disease through epigenetic mechanisms.”

The study hypothesizes that attachment of methyl compounds to specific regions of DNA (methylation) leads to development of MDD. Methyl groups involved in DNA methylation can be generated within the human body or consumed via leafy vegetables and other foods containing folic acid.

“Epigenetic modifications including DNA methylation could occur any time during a person’s lifespan, from as early as in utero to adulthood. Once modified, the gene will express differently (most of the time erroneously) which in turn causes disease,” says Zhao.

The researchers will compare the DNA of twin pairs only one of which has MDD. The study will include 180-200 twin pairs from the University of Washington Twin Registry, which has collected information from over 8,000 twin pairs. The researchers will look for patterns of methylation common to the DNA of twins with MDD but not in the DNA of twins without depressive disorder. “We expect to identify novel epigenetic markers associated with MDD,” says Zhao.

The researchers also will examine postmortem brain tissue of MDD patients to determine if the same associations are present.

“The work is expected to have an important impact,” says Zhao. “Genes with both differential methylation and expression are likely to provide novel targets for prevention, intervention and treatment for depression and its related psychiatric conditions in addition to advancing the fields of psychiatric genetics.”

Tulane University has received a five-year $3.13 million grant from the National Institute of Mental Health to study the causes of major depressive disorder (MDD).

“Major depressive disorder is a devastating psychiatric disorder that affects millions of Americans,” says Dr. Jinying Zhao, associate professor of epidemiology at the Tulane School of Public Health and Tropical Medicine and principal investigator.

The research team wants to identify alterations of genetic makeup (“epigenetic” changes) that may cause the disorder. “Epigenetic changes are related to many psychosocial, behavioral and/or environmental factors,” says Zhao. “For MDD, stressful early life events are believed to play an important role in causing the disease through epigenetic mechanisms.”

The study hypothesizes that attachment of methyl compounds to specific regions of DNA (methylation) leads to development of MDD. Methyl groups involved in DNA methylation can be generated within the human body or consumed via leafy vegetables and other foods containing folic acid.

“Epigenetic modifications including DNA methylation could occur any time during a person’s lifespan, from as early as in utero to adulthood. Once modified, the gene will express differently (most of the time erroneously) which in turn causes disease,” says Zhao.

The researchers will compare the DNA of twin pairs only one of which has MDD. The study will include 180-200 twin pairs from the University of Washington Twin Registry, which has collected information from over 8,000 twin pairs. The researchers will look for patterns of methylation common to the DNA of twins with MDD but not in the DNA of twins without depressive disorder. “We expect to identify novel epigenetic markers associated with MDD,” says Zhao.

The researchers also will examine postmortem brain tissue of MDD patients to determine if the same associations are present.

“The work is expected to have an important impact,” says Zhao. “Genes with both differential methylation and expression are likely to provide novel targets for prevention, intervention and treatment for depression and its related psychiatric conditions in addition to advancing the fields of psychiatric genetics.”

Arthur Nead (Originally published in the  Tulane New Wave)

Advertisements

About Tulane University SPHTM

Tulane's School of Public Health and Tropical Medicine is the oldest school of public health in the country and the only American school of tropical medicine. Our mission is to advance public health knowledge, promote health and well-being, and prevent disease, disability, and premature mortality. This is accomplished through academic excellence in education of public health professionals, rigorous scientific research of public health problems, creative partnerships to advance the practice of public health, and innovative service to the local, national, and international public health community.
This entry was posted in Spring/Summer 2014 and tagged , , , , , , , , , . Bookmark the permalink.

One Response to Focus on Depression: Major depressive disorder target of $3.13 million Tulane study

  1. Pingback: Focus on Depression: Feeling depressed may weigh on women | Global Health Spring/Summer 2014

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s